What is the recommended dose of Ampisulbac (sulfonamide antibiotic) for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ampicillin-Sulbactam Dosing for Pediatric Patients

For pediatric patients, ampicillin-sulbactam should be dosed at 100-200 mg ampicillin/kg/day divided every 6 hours, with infants receiving 100-150 mg ampicillin/kg/day divided every 6 hours. 1

Standard Dosing Recommendations

Infants

  • 100-150 mg ampicillin/kg/day divided every 6 hours 1
  • This translates to approximately 25-37.5 mg ampicillin/kg/dose every 6 hours

Children (Beyond Infancy)

  • 100-200 mg ampicillin/kg/day divided every 6 hours 1
  • This translates to approximately 25-50 mg ampicillin/kg/dose every 6 hours
  • The sulbactam component is administered in a 2:1 ratio (ampicillin:sulbactam) 2

Optimized Dosing for Severe Infections

For empiric therapy of community-acquired pneumonia or severe infections, the higher end of the dosing range (75 mg/kg four times daily, equivalent to 300 mg/kg/day) provides better pharmacodynamic coverage against common respiratory pathogens. 3

  • The FDA-approved maximum dosage of 75 mg/kg four times daily achieves adequate coverage against Streptococcus pneumoniae (MIC90 = 2 μg/mL) and Haemophilus influenzae (MIC90 = 4 μg/mL) 3
  • Lower dosing of 45 mg/kg three times daily may be insufficient for empiric therapy when MIC values are elevated 3

Clinical Efficacy Data

The combination demonstrates excellent clinical outcomes in pediatric populations:

  • 98.7% cure rate across various pediatric infections including skeletal, intrathoracic, and soft tissue infections 4
  • Well-tolerated with minimal adverse effects (only 1 rash reported in 78 patients that did not require discontinuation) 4
  • Treatment duration typically ranges from 8-23 days depending on infection severity 4

Pharmacokinetic Considerations

Age does not significantly affect the pharmacokinetics of ampicillin-sulbactam in children aged 1-12 years, allowing for weight-based dosing without age-specific adjustments. 2, 3

  • Mean half-life: 0.77 hours for ampicillin and 0.81 hours for sulbactam 2
  • Peak serum concentrations: 177-200 μg/mL for ampicillin and 82-102 μg/mL for sulbactam 2
  • Pharmacokinetics in pediatric patients are comparable to adults 2

Important Clinical Caveats

  • Neonatal dosing differs significantly: For neonates, refer to ampicillin dosing guidelines which vary by postnatal age and weight, as specific ampicillin-sulbactam neonatal data is limited in the guidelines 1
  • The combination should be dosed based on the ampicillin component, with sulbactam automatically included in the 2:1 fixed ratio 2
  • For infections requiring higher ampicillin doses (such as meningitis), consider using ampicillin alone rather than ampicillin-sulbactam to achieve necessary CNS penetration 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacokinetics of ampicillin and sulbactam in pediatric patients.

Antimicrobial agents and chemotherapy, 1999

Research

Sulbactam/ampicillin in the treatment of pediatric infections.

Diagnostic microbiology and infectious disease, 1989

Guideline

Ampicillin Dosage in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.